Independent reviewers examined two online literature databases for level I or II evidence on treatment for chondral lesions of the knee. The review included 12 studies encompassing 730 knee surgery patients. The patients either underwent microfracture, osteochondral autograft transplantation, first-generation autologous chondrocyte implantation or next generation ACI.
The study authors found:
1. Mean functional outcomes score increases were:
• Microfracture: 23
• Osteochondral autograft transplantation: 19
• First generation ACI: 20
• Second generation ACI: 35
2. Second generation ACI patients reported significantly greater change in functional outcomes scores than all other treatments.
3. Average cost-per-point change in the functional outcome scores were:
• Microfracture: $200.59
• Osteochondral autograft transplantation: $313.84
• First generation ACI: $536.59
4. The study authors concluded all four procedures were surgically effective and increased functional outcomes scores in patients. The second generation ACI patients reported greater outcome scores.
5. The most cost-effective treatment was microfracture while the least cost-effective treatment was first generation ACI.
More articles on sports medicine:
NCAA Division III Hall of Fame inducts former Olympian studying to become an orthopedist
Tulane Institute of Sports Medicine creates professional athlete care
The 25 fittest cities in America
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
